Cities are, in many ways, businesses that can never close. Dan and Axios' Kim Hart explore how coronavirus presents particular challenges for cities when it comes to encouraging remote work and keeping services running, and how they're handling it.

Go deeper: Coronavirus throws cities into panic mode

Go deeper

Updated Sep 18, 2020 - Health

World coronavirus updates

Expand chart
Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Axios Visuals

Though health workers represent less than 3% of the population in many countries, they account for around 14% of the coronavirus cases reported to the World Health Organization, WHO announced Thursday.

Why it matters: The WHO called on governments and health care leaders to address threats facing the health and safety of these workers, adding that the pandemic has highlighted how protecting them is needed to ensure a functioning health care system.

FDA authorizes Abbott's $5 rapid COVID-19 test

Results from the BinaxNOW COVID-19 Ag Card test will be available in roughly 15 minutes. Photo: Courtesy of Abbott Laboratories.

Abbott Laboratories said Wednesday it received emergency use authorization (EAU) from the Food and Drug Administration for its COVID-19 test that works without lab equipment.

The big picture: Abbott said it will ramp up production of its "highly portable," $5 tests to 50 million by the beginning of October.

Aug 26, 2020 - Health

Carson: It would "behoove" us to move forward with COVID-19 vaccine and treatment testing

Screenshot: Axios Events

Housing and Urban Development Secretary Ben Carson says "this is not necessarily the time to take everything slowly" when it comes to the Trump administration's approach to getting vaccines and treatments to the public.

Why it matters: Carson's comments, made Wednesday during an Axios virtual event, came days after the Food and Drug Administration announced an emergency use authorization (EUA) for treating the coronavirus with convalescent plasma. President Trump accused the agency of slow-walking the development and approval of vaccines and therapeutics to hurt him politically.